Fetzima (大うつ病性障害)：医薬品市場予測及び分析（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
2.3 Upcoming Related Reports 10
3 Disease Overview 11
3.1 Etiology and Pathophysiology 11
3.1.1 Etiology 11
3.1.2 Pathophysiology 11
3.2 Classification 13
3.3 Symptoms and Subtypes of Major Depressive Disorder 15
3.4 Prognosis 16
3.5 Quality of Life 16
4 Disease Management 17
4.1 Diagnosis and Treatment Overview 17
4.1.1 Diagnosis 17
4.1.2 Treatment Guidelines and Leading Prescribed Drugs 18
4.1.3 Clinical Practice 21
5 Competitive Assessment 26
5.1 Overview 26
6 Fetzima (Levomilnacipran) 28
6.1 Overview 28
6.2 Efficacy 29
6.3 Safety 30
6.4 SWOT Analysis 32
6.5 Forecast 32
7 Appendix 34
7.1 Bibliography 34
7.2 Abbreviations 36
7.3 Methodology 38
7.4 Forecasting Methodology 38
7.4.1 Diagnosed MDD Patients 38
7.4.2 Percent of Drug-Treated Patients 38
7.4.3 General Pricing Assumptions 39
7.4.4 Individual Drug Assumptions 39
7.4.5 Generic Erosion 40
7.5 Physicians and Specialists Included in this Study 41
7.6 About the Authors 43
7.6.1 Analyst 43
7.6.2 Therapy Area Directors 43
7.6.3 Global Head of Healthcare 44
7.7 About GlobalData 45
7.8 Disclaimer 45